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It is known that tumor cells could differ practically 
by all observed cell characteristics such as duration 
of mitotic cycle, migration ability and reaction on the 
action of endogenous and exogenous factors. Such 
variability could be observed also in cell populations 
derived from a single cell (clones), and one may ascribe 
it to heterogeneity of cell population or in more common 
sense to clonal heterogeneity [1, 2]. In all mentioned 
cases, heterogeneity is caused by existence of cell 
subpopulations with different properties (genotypic or 
phenotypic heterogeneity) as well as variability of each 
separate subpopulation composed from proliferating 
and quiescent cells (proliferative heterogeneity).
Numerous studies have shown that upon cultivation 
at equal conditions in vitro, cell population (or a clone) 
is characterized by great variability of growth kinetic 
curves [3, 4]. The analysis with the use of mathematical 
model has revealed that such phenomenon is caused 
by proliferative heterogeneity of population at initial 
stage of its growth, in particular, by the number of 
via ble cells in the population and by the ratio between 
dividing and quiescent cells [5].
It is known also that microenvironment could influ-
ence significantly proliferative heterogeneity of tumor 
cell population and its growth kinetics. Deficiency of 
nutrient substrates (oxygen, glucose etc) could shift cell 
ratio toward elevated number of quiescent cells (G10 as 
well as G20) and decreased fraction of viable cells [6, 
7]. Influence of mitogenic agents (growth factors etc.) 
may lead to elevation of the pool of actively proliferating 
cells and growth rate of the population. Cytoreductive 
antitumor preparations (cycle-specific and phase-
specific ones) alter significantly composition of tumor 
cell population [8]. Moreover, efficacy of their action 
depends significantly on proliferative heterogeneity of 
tumor cells, because the majority of anticancer drugs 
possesses cycle-specific activity, i. e. are mainly effec-
tive against proliferating cells [9]. One should note that 
antiangiogenic therapy belongs to arsenal of cytoreduc-
tive anticancer therapy, and its goal is to reduce the pool 
of tumor cells via formation of metabolic stress (part of 
which is deficiency of nutrient substrates) by inhibition 
of tumor neovascularization.
Despite existence of numerous publications, the 
problem of control of growth of heterogeneous cell 
populations is far from being solved yet. At the same 
time the analysis of growth kinetics of cell population 
including characteristics of its proliferative hetero-
geneity could be useful for prediction of tumor pro-
gression and reaction of tumor to chemotherapy and 
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irradiation [10–12]. It’s quite necessary to understand 
the mechanisms that underlay diversification of kinetic 
repertoire of tumor cells and providing their maximal 
survival. To answer this question one should reveal 
the characteristics of cell assembly that determine 
changes in growth kinetics and composition of cell 
population, and the only way to do it — is the applica-
tion of mathematical model [13, 14].
That’s why the aim of present work was analysis 
of growth kinetics and proliferative heterogeneity of 
Lewis lung carcinoma (LLC) cells during their growth 
in monolayer for 5 days without replacement of culture 
medium (unfed culture). One should note that the 
conditions of tumor cells cultivation in unfed culture 
that provide depletion of incubation medium from 
energetic and plastic substrates as well as accumula-
tion of metabolic products of cells (elevation of lactate 
content, decrease of pH, accumulation of different 
growth factors produced by cells etc.) are modeling 
tumor cell microenvironment in the regions of tumor 
distant from blood vessels [4, 15]. Such regions are 
characteristic for malignant tumors and develop due 
to higher growth rate of tumor mass compared to that 
of new vessels, or as a result of application of antivas-
cular or antiangiogenic therapy [16]. In this context, 
kinetic characteristics of cell growth in the frame of 
unfed culture model may reflect the degree of tumor 
cell sensitivity to antiangiogenic therapy. This point is 
important because there are no methods for prognosis 
of sensitivity of tumor to such therapy and evaluation 
of its efficacy [17], whilst high cost of antiangiogenic 
therapy and the necessity of its prolonged administra-
tion (as a rule, life-time one) dictates the necessity for 
the development of new preparations [18, 19].
MATERIALS AND METHODS
Cancer cell line and culture conditions. Lewis lung 
carcinoma (LLC, National Bank of Cell Lines and Cancer 
Strains, IEPOR) cells were used in this work. Stock culture 
was maintained in RPMI 1640 medium supplemented 
with 10% fetal bovine serum (FBS, Sigma), 2 mM L-glu-
tamine and 40 μg/ml gentamycine at 37 °С in incubator 
with humidified atmosphere containing 5% CO2.
All experiments were started from stock cultures 
maintained in exponential growth. The experiments 
were begun by seeding cells in 7 ml complete medium 
supplemented with 15% FBS in 6-cm tissue culture 
dishes. After 16 h of preincubation the culture medium 
was replaced with fresh one. This point was considered 
as starting time 0 h. After incubation at each time point, 
the cells were harvested by scraping all attached cells 
from culture dishes (with light microscope control) 
using a scraper, collected by centrifugation, stained 
with trypan blue and counted using a hemocytometer. 
Concurrently the number and viability of un-attached 
cells in supernatant were determined.
For “unfed” culture experiments the cells were in-
cubated during 5 days (initial density of viable cells at 
starting time point was 0.15 ± 0.02 millions cells/dish). 
In case of comparative “unfed/fed” culture study the 
cells were incubated during 4 days (initial density of 
viable cells at starting time point was 0.24 ± 0.01 mil-
lions cells/dish) with the replacement of medium with 
the fresh one every day.
All the experiments were performed in a duplicate.
The level of glucose in culture media was deter-
mined by enzymatic glucose-oxidase method with using 
glucose assay kit (Sigma, cat. No GAGO-20) according to 
manufacturer’s protocol. For that medium samples were 
collected, centrifuged at 1000 g and stored at –20 °С until 
glucose concentration was analyzed. Glucose concen-
tration in complete culture medium samples were also 
measured before experiments in order to obtain starting 
values. The experiments were performed at a glucose 
concentration of 1.98 mg/ml (11 mM).
The level of VEGF was detected in cell culture 
supernatants in all above indicated points of time of 
the tumor cell growth by sandwich enzyme-linked im-
munosorbent assay (ELISA) with using mouse VEGF 
kit (R & D System DuoSet ELISA Development kit, cat. 
No DY493) according to the manufacturer’s protocol.
The rate of VEGF protein production (PRVEGF) 
by LLC cells was calculated using the formula (2) by 
numerical integration method.
 V × ∆CVEGFPRVEGF (∆ti) = ————— pg/h/10
6 cells, (2)
 t (i + 1)
 ∫N (t) × dt t (i)
where PRVEGF (∆ti) — VEGF production rate (mean value) 
in the range time from t (i) to t (i + 1); ∆CVEGF — differ-
ences between VEGF concentration at time t (i + 1) and 
it concentration at time t (i); V — the culture medium 
volume; N (t) — number of viable cells (X + Y) at time 
point t in the range {t (i), t (i + 1)}.
To analyze VEGF stability 3-day cell culture su-
pernatants was collected and incubated during 7 days 
at 37 °С. Daily measurements of VEGF in supernatant 
aliquots as described above showed that changes of its 
level during 7 days was less than 5% of the initial one.
Mathematical modeling of growth kinetics of 
cancer cells. The phenomenological model of the 
growth kinetics of a proliferative heterogenic cancer 
cell population detailed in [5, 20] is used as the basic 
mathematical model. The main biological assumptions 
underlying of the model are briefly as follows (Fig. 1):
• The cancer cell population consists of prolifera-
ting, quiescent and dead cells;
• Under depletion of nutritional substrates the cells 
lose their ability to divide. In that case the cells transit 
from the stage of proliferation to the resting stage;
• The rate of cell transition from proliferation to 
quiescence depends upon the concentration of the 
main energy substances in cell incubation medium 
such as oxygen and glucose. Since oxygenation in 
experimental conditions was constant, function of 
cell transition from proliferative state to quiescence is 
considered to depend upon solely the concentration 
of glucose in cell incubation medium;
• Quiescent cells can be involved into proliferation 
(under action of mitogenic factors) or may die;
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• Cells are growing in monolayer (two-dimensional 
growth), which provide for all cells equal availability to 
nutrient substances;
• Cells are not exposed to the exogenic cytotoxic 
(cytostatic) agents and mitogenic factors.
Proliferating cells
(X)
Resting (quiescent) cells
(Y)
Dead cells
(Z)
Glucose
(G)
m
b ~ TC-1
P
G
Fig. 1. Block-scheme of mathematical model for 2-D growth 
kinetics of cancer cells
In the framework of such assumptions the growth 
kinetics of cancer cell population can be described by 
the following system of differential equations (1):
dX/dt = b × X – PG × X
dY/dt = PG × X – m × Y
dZ/dt = m × Y (1)
dG/dt = –(a1 × X + a2 × Y)/V
PG = k1 × exp(–k2 × G),
where X, Y, Z — the number of proliferating, resting 
and dead cells at point of time t (i), correspondingly; 
G — glucose concentration; b and m — proliferating and 
death rates, correspondingly; a1 and a2 — consumption 
rate of glucose by proliferating and resting cells, cor-
respondingly; V — culture medium volume. It should 
be mentioned that proliferating rate (parameter b) of 
cancer cells in the framework of exponential stage of 
monolayer growth is inversely proportional to the dura-
tion of the mitotic cycle (TC) with the constant of propor-
tionality close to 1.0. The function of cell transition from 
proliferating to resting state (PG) is assumed to depend 
on glucose concentrations. Parameter k1 equals to the 
maximum value of transition rate. Parameter k2 reflects 
the glucose sensitivity of transition rate.
In order to estimate the model parameters, reflec-
ting kinetic characteristics of cell growth and prolifera-
tive heterogeneity, a non-linear regression program, 
which is based on the SLEXIPLEX procedure, has been 
used. In the framework of the fitting algorithm for 
every step of the sliding in the parameter space the 
numerical solution of the system (1) has been calcu-
lated on the interval {0,t(N)} by Eiler method (where N 
is a number of observed data) [5].
The statistical analysis of the results was car-
ried out using descriptive methods, t-test, correlation 
analysis and nonlinear regressive analysis.
RESULTS AND DISCUSSION
The results of the study of growth kinetics of LLC 
cells and dynamics of alteration of glucose level in 
incubation medium of the cells grown as unfed cul-
ture for 5 days are presented on Fig. 2. The study has 
shown that changes in the number of viable LLC cells 
possesses non-monotonous character — during first 
two-three days of growth the number of cells rose ex-
ponentially, with following decrease after the maximal 
level was achieved. At the same time the decrease of 
number of viable cells and increase of number of dead 
cells has been observed upon complete depletion of 
culture medium by glucose content; this result is in 
agreement with hypothesis on an important role of 
glucose for proliferative activity of LLC cells. Really, 
apart from the fact that glucose as well as oxygen is the 
main energetic substrate, it is also a basic plastic sub-
strate — more than 80% of all phosphorus-containing 
cell metabolites are synthesized from glucose.
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Fig. 2. The growth kinetics of LLC cells (a) and changes of 
glucose level (b) in incubation medium during cell growth in 
unfed culture. Symbols — experimental data; lines — model 
approximation obtained from the best fit of mathematical model 
(1) to experimental data
The fact that observed growth inhibition of LLC 
cells is resulted from the substrate depletion of culture 
medium (where glucose level may be considered at 
least as a marker of this depletion) rather than from 
cell density inhibition of cell proliferation is confirmed 
by the results of the investigations of growth kinetics 
of LLC cells growing in culture medium with nutrients 
redundancy (“fed culture”). As it seen in Fig.3 in the 
lack of nutrient deficiency LLC cells display expo-
nential growth amounting to 20 × 106 cells per dish 
during 4 days of growth, that is about 2.5 times more 
than confluent monolayer number (coming to about 
6.5 × 106). In “unfed culture” LLC cells show growth 
deceleration beginning from 48 h that is synchro-
nized with a decrease of glucose concentration lower 
than physiological level (which is at close range to 
0.9 mg/ml). It should be noted that during LLC growth 
as “fed culture” (as well as “unfed culture”) overwhelm-
ing majority of cells grew on the plastic — number of 
viable detached cells counted in culture medium was 
less than 7% of the total viable cells per dish.
Obtained results completely correspond to pecu-
liarities of malignant cells. Really it is well known that 
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deregulation of main cellular functions (proliferation, 
differentiation and cell motility) is an attribute of ma-
lignant cells [21]. Intracellular mechanisms of normal 
cells provide for both contact inhibition of cell motility 
and inhibition of cell proliferation due to differentiation or 
high cell density. In contrast to normal cell the malignant 
one is characterized by the absence of contact inhibition 
of cell motility (moreover may display contact-activated 
migration [22]) and the abnormalities of differentiation 
processes. Furthermore from the set of intracellular 
mechanisms resulting in high density inhibition of 
normal cell proliferation including cohesion/contact 
(substrate independent) mechanisms and substrate-
dependent (resulted from the decrease in availability of 
cells to nutrient) mainly the latter is realized in cancer 
cells [23]. That’s why cancer cells manifest exponential 
3-D growth under the absence of substrate deficit.
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Fig. 3. Growth kinetics of LLC cells cultivated under deficit (“un-
fed” culture) or redundancy (“fed” culture) of nutrients
As one may see on Fig. 2, model (1) precisely de-
scribe growth kinetics of tumor cell population upon 
their growth without replacement of culture medium; 
which allowed to determine growth kinetic parameters 
(model parameters) of LLC cells and to predict the 
changes in proliferative heterogeneity. The rate of LLC 
cell division (which is determined by ratio ln (2)/b) is 
equal to 14.85 ± 1.5 h (Table 1). Glucose dependence of 
cell transition rate from proliferation to resting state pos-
sesses a pronounced two-phase character (Fig. 4, a). 
At a wide range of relatively high glucose concentrations 
(> 0.7 mg/ml) the transition rate is quite small. At con-
centrations lower than 0.7 mg/ml, the rate of transition 
swiftly increases (Fig. 4, b) resulting in sharp change 
in cellular composition (Fig. 5). It should be mentioned 
that PG reflects a fraction of dividing cells switching to 
resting state. The real number of cells that pass to qui-
escent state for the day at glucose level G equals to the 
product of transition rate and number of dividing cells 
at the same glucose level. For instance when medium 
glucose concentration is about 0.7 mg/ml the transition 
rate is higher than 10–5 (day–1) and number of quiescent 
cells appeared for the day varies from 20 to 5000 (taking 
into account the statistical errors of parameters k1 and 
k2). Glucose concentration about 1.0 mg/ml (at which 
transition rate is less than 10–6 day–1) can be considered 
as the threshold value for single cell reduction of which 
stimulates the transition of cell from proliferating to 
resting state.
Table 1. Growth kinetic parameters of LLC cells growing as unfed culture
Growth kinetic parameters Units Value (M ± m)
b Day-1 1.12 ± 0.12
k1 Day
-1 9.7 ± 4.2
k2 (mg/ml)
-1 19.8 ± 8.7
a1 mg/day/10
6 cells 4.1 ± 0.6
a2 mg/day/10
6 cells < 0.1 ± 0.06
m day-1 0.3 ± 0.05
At an interval from 70 to 90 h, practically all pro-
liferating cells transit to a resting state. The rate of 
quiescent cell death is relatively low, and this is in 
part caused by too low level of glucose consumption 
compared to proliferating cells. These two facts are 
providing slow decrease of the pool of quiescent cells 
in the population, thus significantly increasing their 
chance to survive upon nutritional deficiency.
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Fig. 4. LLC transition rate from proliferating to resting state as 
a function of growth time (a) and glucose level in incubation 
medium (b) predicted by the mathematical model (1)
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Fig. 5. The changes of cellular composition during LLC growth 
in unfed culture (model prediction)
It was shown that during LLC cells growth the level 
of VEGF in incubation medium is increasing monoto-
nously (Fig. 6). Evaluation of VEGF production rate 
(PRVEGF) has shown monotonous decrease of this in-
dex (Fig. 7). Observed decrease of PRVEGF could not be 
explained by VEGF degradation in incubation medium 
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(our results displayed the stability of VEGF molecule 
during investigations). Decrease of VEGF production 
rate, at least at first three days of LLC cells growth 
could nor be explained by the changes in cell number 
and cellular composition, because at this period eleva-
tion of the volume of LLC cell population is completely 
determined by the growth of its actively proliferating 
subpopulation at constant number of quiescent cells 
and the absence of cell death. Fall of VEGF produc-
tion rate may result from either decrease in glycolysis 
intensity (due to glucose level reduction) or inhibition 
by VEGF itself (through allosteric mechanism). Intere-
stingly that our results showed that VEGF production 
rate may depend on LLC cell seeding density. As it seen 
in Table 2 the PRVEGF of LLC cells seeding at decreased 
density (by 33%) in 24 h was on 32% (p < 0.05) higher 
than that of cells seeding at greater density. Such 
inverse dependence is justified in the framework of 
“growth strategy” of cancer cells, because VEGF was 
shown to promote cancer cell survival and proliferative 
activity via paracrine and/or autocrine mechanisms 
[24, 25]. Meanwhile the mechanisms underlying this 
phenomenon are not totally clear.
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Table 2. Influence of LLC cell density at the beginning of the growth on 
VEGF production rate
Number of viable cells (106) VEGF 
concentrations 
after 24 h pg/ml
VEGF production 
rate pg/
(106 cells × h)
0 h 24 h
0,110 ± 0,005 0.24 ± 0.005 37.4 ± 2.9 63.0 ± 3.0
0,166 ± 0,026 0,51 ± 0.052 54,3 ± 4.2 47,4 ± 7.3
It should be mentioned that growth of LLC cells 
in unfed culture is accompanied by changes in a 
wide spectrum of growth medium characteristics 
(biochemi cal and chemical composition, physical 
properties). Each of these factors can affect VEGF 
production rate of LLC cells. For instance it is well 
known that changes in pH level may alter VEGF pro-
duction rate through modulation of VEGF expression 
[26–28]. However in a background of minor changes in 
growth medium occurred during first 24 h it is difficult 
to explain such significant and quite rapid changes 
in production rate of LLC cells by modulation of gene 
expression. Most likely it should be mediated through 
posttranscriptional events. After three days of growth 
a significant decrease of actively proliferating cells 
upon slight changes of viable cell number contributes 
for more progressive decrease of PRVEGF.
So, the carried out investigations showed that 
elaborated mathematical model provided an adequate 
qualitative and quantitative description of the behavior 
of cancer cells growing as “unfed culture” and gave 
the possibility to predict the influence of glucose level 
on proliferative heterogeneity of cancer cell popula-
tions. Analysis of LLC growth kinetics by mathematical 
model has shown that LLC cells possess high prolifera-
tive activity at wide concentration range of glucose in 
culture medium. Significant inhibition of proliferation is 
observed at glucose content lower than 0.3 mg/ml, i. e. 
at concentrations 3-fold lower than physiologic one. At 
mentioned low concentrations of glucose the rate of 
cell death is quite small, providing high level of LLC cell 
viability upon nutritional deficiency. Such dependence 
between LLC cell survival (and proliferative heterogene-
ity) and glucose level may indicate a tolerance of LLC to 
metabolic stress, originated in a background of tumor 
angiogenic inhibition. This prediction is confirmed by 
the results of the investigations of anticancer activity 
of aconitine-containing agent BC1 with antiangiogenic 
mechanism of action [29] that showed the low efficacy 
of this agent against LLC [30].
It should be noted that the study of growth kinetics 
and proliferative heterogeneity of cancer cells growing 
as unfed culture could be considered as experimental 
model for development of the methods for estimation 
of sensitivity of tumor cell to antiangiogenic cancer 
therapy.
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АНАЛИЗ КИНЕТИКИ РОСТА И ПРОЛИФЕРАТИВНОЙ 
ГЕТЕРОГЕННОСТИ КЛЕТОК КАРЦИНОМЫ ЛЕГКОГО ЛЬЮИС, 
РАСТущИх БЕЗ СМЕНЫ ПИТАТЕЛЬНОЙ СРЕДЫ
Цель: провести анализ кинетики роста и пролиферативной гетерогенности клеток карциномы легкого Льюис (LLC) при 
их росте в монослое на протяжении 5 сут без замены культуральной среды (unfed culture). Методы: иммуноферментный 
метод определения уровня продукции VEGF опухолевыми клетками; глюкозооксидазный метод определения уровня глюкозы 
в среде инкубации; математическое моделирование. Результаты: предложенная математическая модель хорошо описывает 
экспериментальные данные, что позволяет определить кинетические параметры роста клеток LLC и предсказать изменения 
количества пролиферирующих и покоящихся клеток (пролиферативная гетерогенность) в процессе их роста. Кинетика 
роста клеток LLC носит немонотонный характер — в течение первых 3 сут их роста количество клеток экспоненциально 
увеличивается и далее, по достижении максимальной плотности, снижается. В то же время уменьшение количества живых 
клеток/увеличение количества мертвых клеток тесно связано с истощением глюкозы в среде инкубации. Зависимость 
скорости перехода клеток из состояния пролиферации в состояние покоя от содержания глюкозы в среде инкубации 
имеет выраженный двухфазный характер. В широком диапазоне относительно высоких концентраций глюкозы (> 1,0 мг/
мл) скорость перехода близка к нулю. При концентрациях < 0,7 мг/мл скорость перехода стремительно возрастает, что 
приводит к резким изменениям клеточного состава клеточной популяции. В интервале от 70 до 90 ч практически все 
пролиферирующие клетки переходят в состояние покоя. Скорость гибели покоящихся клеток относительно низкая, что, 
в частности, связано с низким уровнем потребления глюкозы этими клетками по сравнению с таковым пролиферирующими 
клетками. Установлено, что в процессе роста скорость продукции VEGF клетками LLC монотонно снижается, несмотря 
на то, что в среде инкубации его уровень монотонно нарастает. Выводы: низкая зависимость скорости перехода клеток 
LLC из состояния пролиферации в состояние покоя от уровня глюкозы (> 0,7 мг/мл) в среде инкубации, а также низкий 
уровень их гибели обусловливает медленное снижение пула покоящихся клеток в популяции, что значительно повышает 
их шансы выжить в условиях дефицита питательных субстратов.
Ключевые слова: карцинома легкого Льюис, кинетика роста, глюкоза, пролиферативная гетерогенность, математическое 
моделирование.
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